LJ000328, a novel ALK2/3 kinase inhibitor, represses hepcidin and significantly improves the phenotype of IRIDA
Audrey Belot
(1)
,
Ophélie Gourbeyre
(1)
,
Alexis Fay
(1)
,
Anais Palin
(1)
,
Celine Besson-Fournier
(1)
,
Chloé Latour
(1)
,
Corey Hopkins
(2)
,
George Tidmarsh
(3)
,
Hélène Coppin
(1)
,
Marie-Paule Roth
(1)
,
Ritter, Matthew
(3)
,
Charles Hong
(4)
,
Delphine Meynard
(1)